Alexander Mark Schobel

Alexander Mark Schobel

Chief Innovation and Technology Officer at Aquestive Therapeutics, Inc.

Are you Alexander Mark Schobel? Claim your profile
 
  • IDENTIFY executive and board member connections in Alexander Mark Schobel's network.
  • FOLLOW changes in Alexander Mark Schobel's employment.
  • CONNECT with Alexander Mark Schobel through your network of contacts.

Alexander Mark Schobel's Executive Work History


Current
Chief Innovation and Technology Officer,
Chief Innovation and Technology Officer
Aquestive Therapeutics, Inc. 424B4 on 07/26/2018
Aquestive Therapeutics, Inc.
Past
To view Alexander Mark Schobel's complete executive work history,
Age
66
 

Alexander Mark Schobel's Biography


Mark Schobel was appointed as Chief Innovation & Technology Officer of Aquestive in 2014 after serving as the Company’s Chief Executive Officer, Co-President and a member of its Board of Directors since November 2005. From March 2001 to November 2005, he was the Global Head of New Technology and Product Innovation for the Consumer Health Business Unit at Novartis where he pioneered thin film delivery of systemic drugs. Prior to Novartis, Mr. Schobel held various general management positions with Reed & Carnrick Pharmaceuticals, Warner-Lambert, and Pharmaceutical Formulations Inc.

Source: Aquestive Therapeutics, Inc. on 12/14/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Alexander Mark Schobel. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Alexander Mark Schobel's network.
  • FOLLOW changes in Alexander Mark Schobel's employment.
  • CONNECT with Alexander Mark Schobel through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Alexander Mark Schobel

Alexander Mark Schobel's Connections (20)


Daniel Barber
President, Chief Executive Officer and Director, Aquestive Therapeutics, Inc.
Marco Taglietti M.D.
President, Chief Executive Officer and Director, SCYNEXIS, Inc.
Julie Krop M.D.
Chief Medical Officer, PureTech Health plc
Gary H Slatko
Former SVP, Chief Medical Officer, Aquestive Therapeutics, Inc.
A. Ernest Toth Jr.
Senior Vice President and Chief Financial Officer, Aquestive Therapeutics, Inc.
Timothy E. Morris
Chief Financial Officer, Burrard Pharmaceuticals Enterprises, Ltd.
Kenneth Truitt M.D.
Chief Medical Officer, Aquestive Therapeutics, Inc.
James S. Scibetta
Chief Executive Officer, ImmuneID
Theresa Wood
Senior Vice President, Human Resources, Aquestive Therapeutics, Inc.
Keith J. Kendall
Former President, Chief Executive Officer and Director, Aquestive Therapeutics, Inc.